ANIP News and Press, ANI Pharmaceuticals Inc. From 11/06/23

2023-11-06 10:28:09 ET Summary ANIP's PPS has gained 63.41% YTD and is expected to continue growing. ANIP should record its fifth consecutive quarter beating earnings and revenue consensus. ANIP's Sovuna, a unique version of Hydroxychloroquine sulfate, and a new 1-ml vial vers...

BAUDETTE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two upcoming healthcare conferences as follows: Trui...

BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2023 financial results on Wednesday, November 8, 2023, prior to the market open. N...

2023-10-18 07:02:30 ET More on ANI Pharmaceuticals ANI Pharma: Slow And Steady Revenue Generator ANI Pharma wins FDA nod for generic Estradiol tablets ANI Pharma granted FDA nod for generic Estradiol Gel For further details see: ANI Pharmaceuticals disclo...

2023-10-04 06:55:04 ET More on ANI Pharmaceuticals ANI Pharma: Slow And Steady Revenue Generator ANI Pharma wins FDA nod for generic Estradiol tablets ANI Pharma granted FDA nod for generic Estradiol Gel Seeking Alpha’s Quant Rating on ANI Pharmaceutic...

Cortrophin Gel is the only FDA-approved purified corticotropin (ACTH) indicated for the treatment of appropriate patients with acute gouty arthritis flares New 1-mL size furthers ANI’s commitment to providing ACTH options for appropriate acute gouty arthritis flare patients and the...

BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Global Healthcare Conference 2023 in New York City...

2023-09-12 08:17:06 ET More on ANI Pharma Seeking Alpha’s Quant Rating on ANI Pharmaceuticals Historical earnings data for ANI Pharmaceuticals Financial information for ANI Pharmaceuticals ANI Pharma: Slow And Steady Revenue Generator ANI Pharm...

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Estradiol Tablets USP. ANI’s Estradi...

2023-09-12 06:36:06 ET Summary ANI Pharmaceuticals is a revenue-generating pharmaceutical manufacturer with a low market cap. The company's rare disease segment, led by its Purified Cortrophin Gel product, is expected to be its primary growth driver. ANI Pharmaceuticals report...